2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow sterofundin: new trials by email Literature Review of sterofundin trials Research Report on sterofundin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Scandinavian Starch for Severe Sepsis/Septic Shock Trial 6% Hydroxyethyl starch 130/0.4, Ringers acetate - Severe Sepsis, Septic Shock | Phase 3 | Completed | Anders Perner | 804 | 2009-12-01 | 2012-07-10 |
| Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial) 10% Hemohes® (10% Hydroxyethyl starch), Sterofundin® (Ringer lactate solution), Actrapid® (Insulin) - Severe Sepsis, Septic Shock | Phase 3 | Completed | SepNet - Critical Care Trials Group | 600 | 2003-04-01 | 2016-02-11 |
Sepsis (2) · Shock, Septic (2) · Shock (1)
Anders Perner (1) · SepNet - Critical Care Trials Group (1)
Denmark (1) · Finland (1) · Germany (1) · Iceland (1) · Norway (1)
Anders Perner, MD, PhD (1) · Konrad Reinhart, MD (1) · Nicolai Haase, MD (1) · Thomas Deufel, MD (1)
PMID 18184958, PMID 22738085, PMID 24037226, PMID 24807084, PMID 25907781